المؤلفون: Bridge KS, Sharp TV

المصدر: Future Oncology; May2012, Vol. 8 Issue 5, p491-493, 3p

المؤلفون: Foxler, DE, Bridge, KS, Foster, JG, Grevitt, P, Curry, S, Shah, KM, Davidson, KM, Nagano, A, Gadaleta, E, Rhys, HI, Kennedy, PT, Hermida, MA, Chang, T-Y, Shaw, PE, Reynolds, LE, McKay, Tristan, Wang, H-W, Ribeiro, PS, Plevin, MJ, Lagos, D, Lemoine, NR, Rajan, P, Graham, TA, Chelala, C, Hodivala-Dilke, KM, Spendlove, I, Sharp, TV

مصطلحات موضوعية: lung cancer, HIF-1, LIMD1, Tumour suppressor, Adaptive hypoxic response

وصف الملف: PDF; text

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0a141f0a6a4f2bd9fad1ae52d696f06d

المؤلفون: Zhao W; Department of Biology, University of York, York, UK., Rose SF; Department of Biology, University of York, York, UK., Blake R; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Godicelj A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Smith Building, Boston, Massachusetts, USA., Cullen AE; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Stenning J; Department of Biology, University of York, York, UK., Beevors L; The Institute of Metabolism and Systems Research (IMSR), University of Birmingham, College of Medical and Dental Sciences, Birmingham, UK., Gehrung M; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Kumar S; Chris O'Brien Lifehouse, Sydney, New South Wales, Australia., Kishore K; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Sawle A; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Eldridge M; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Giorgi FM; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy., Bridge KS; Department of Biology, University of York, York, UK.; York Biomedical Research Institute, University of York, York, UK., Markowetz F; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Holding AN; Department of Biology, University of York, York, UK.; York Biomedical Research Institute, University of York, York, UK.; The Alan Turing Institute, Kings Cross, London, UK.

المصدر: Journal of molecular endocrinology [J Mol Endocrinol] 2024 Apr 25; Vol. 73 (1). Date of Electronic Publication: 2024 Apr 25 (Print Publication: 2024).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioScientifica Country of Publication: England NLM ID: 8902617 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-6813 (Electronic) Linking ISSN: 09525041 NLM ISO Abbreviation: J Mol Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/metabolism , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Estrogen Receptor alpha*/metabolism , Estrogen Receptor alpha*/genetics , Gene Expression Regulation, Neoplastic* , E2F2 Transcription Factor*/metabolism , E2F2 Transcription Factor*/genetics, Humans ; Female ; Cell Line, Tumor ; Cell Proliferation/genetics ; Transcription Factors/metabolism ; Transcription Factors/genetics ; Protein Binding ; Promoter Regions, Genetic/genetics ; Signal Transduction ; Cell Cycle/genetics ; Prognosis

المؤلفون: Igarashi KJ; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA., Kucinski I; Wellcome-MRC Cambridge Stem Cell Institute, Department of Haematology, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Chan YY; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Tan TK; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA.; Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA., Khoo HM; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Kealy D; York Biomedical Research Institute, Department of Biology, University of York, United Kingdom., Bhadury J; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA., Hsu I; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Ho PY; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Niizuma K; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA., Hickey JW; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA.; Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA., Nolan GP; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA.; Department of Pathology, Stanford University School of Medicine, Stanford University, Stanford, CA., Bridge KS; York Biomedical Research Institute, Department of Biology, University of York, United Kingdom., Czechowicz A; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA., Gottgens B; Wellcome-MRC Cambridge Stem Cell Institute, Department of Haematology, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom., Nakauchi H; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA.; Division of Stem Cell Therapy, Distinguished Professor Unit, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Wilkinson AC; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.

المصدر: Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3366-3377.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/metabolism, Animals ; Mice ; Hematopoietic Stem Cells/metabolism ; Transplantation, Homologous

المؤلفون: Grey W; York Biomedical Research Institute, Department of Biology, University of York, United Kingdom.; Hematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom., Atkinson S; Hematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom., Rix B; York Biomedical Research Institute, Department of Biology, University of York, United Kingdom., Casado P; Cell Signalling and Proteomics Group, Centre for Genomics and Computational Biology, Bart's Cancer Institute, London, United Kingdom., Ariza-McNaughton L; Hematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom., Hawley C; York Biomedical Research Institute, Department of Biology, University of York, United Kingdom., Sopoena ML; Bioinformatics Core, The Francis Crick Institute, London, United Kingdom., Bridge KS; York Biomedical Research Institute, Department of Biology, University of York, United Kingdom., Kent D; York Biomedical Research Institute, Department of Biology, University of York, United Kingdom., Cutillas PR; Cell Signalling and Proteomics Group, Centre for Genomics and Computational Biology, Bart's Cancer Institute, London, United Kingdom., Bonnet D; Hematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom.

المصدر: HemaSphere [Hemasphere] 2023 Feb 28; Vol. 7 (3), pp. e853. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Rix B; York Biomedical Research Institute, Department of Biology, University of York, York, United Kingdom., Maduro AH; York Biomedical Research Institute, Department of Biology, University of York, York, United Kingdom., Bridge KS; York Biomedical Research Institute, Department of Biology, University of York, York, United Kingdom., Grey W; York Biomedical Research Institute, Department of Biology, University of York, York, United Kingdom.

المصدر: Frontiers in physiology [Front Physiol] 2022 Sep 30; Vol. 13, pp. 1009160. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101549006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-042X (Print) Linking ISSN: 1664042X NLM ISO Abbreviation: Front Physiol Subsets: PubMed not MEDLINE

المؤلفون: Davidson K; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK., Grevitt P; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK., Contreras-Gerenas MF; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK., Bridge KS; York Biomedical Research Institute, University of York, Wentworth Way, York, YO10 5DD, UK., Hermida M; Department of Bioengineering, Imperial College, London, UK., Shah KM; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK., Mardakheh FK; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK., Stubbs M; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK., Burke R; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK., Casado P; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK., Cutillas PR; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK., Martin SA; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK. sarah.martin@qmul.ac.uk., Sharp TV; Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M6 BQ, UK. t.sharp@qmul.ac.uk.

المصدر: Cell death & disease [Cell Death Dis] 2021 Nov 11; Vol. 12 (11), pp. 1075. Date of Electronic Publication: 2021 Nov 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung/*genetics , Intracellular Signaling Peptides and Proteins/*deficiency , LIM Domain Proteins/*deficiency , Lung Neoplasms/*genetics, Animals ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/pathology ; Mice ; Mice, Inbred NOD ; Proof of Concept Study ; Transfection

المؤلفون: Oedekoven CA; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Belmonte M; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Bode D; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Hamey FK; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Shepherd MS; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Che JLC; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Boyd G; York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, UK., McDonald C; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Belluschi S; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Diamanti E; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Bastos HP; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Bridge KS; York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, UK., Göttgens B; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Laurenti E; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Kent DG; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK; York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, UK. Electronic address: david.kent@york.ac.uk.

المصدر: Stem cell reports [Stem Cell Reports] 2021 Jun 08; Vol. 16 (6), pp. 1614-1628. Date of Electronic Publication: 2021 May 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101611300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-6711 (Electronic) Linking ISSN: 22136711 NLM ISO Abbreviation: Stem Cell Reports Subsets: MEDLINE

مواضيع طبية MeSH: Transcriptome*, Arylsulfotransferase/*metabolism , Cell Culture Techniques/*methods , Hematopoietic Stem Cells/*physiology , Signaling Lymphocytic Activation Molecule Family Member 1/*metabolism , Suppressor of Cytokine Signaling Proteins/*metabolism , Transcription Factor AP-1/*metabolism, Animals ; Bone Marrow Transplantation/methods ; Cell Cycle ; Cell Differentiation ; Cells, Cultured ; Cytokines/metabolism ; Hibernation ; Mice ; Mice, Inbred C57BL ; Multiprotein Complexes/metabolism ; Single-Cell Analysis ; Stem Cell Niche

المؤلفون: Foxler DE; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Bridge KS; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Foster JG; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Grevitt P; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Curry S; Faculty of Medicine and Life Sciences, University of Nottingham, Nottingham, UK., Shah KM; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Davidson KM; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Nagano A; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Gadaleta E; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rhys HI; The Francis Crick Institute, London, UK., Kennedy PT; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Hermida MA; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Chang TY; Institute of Microbiology and Immunology, National Yang Ming University, Taipei City, Taiwan., Shaw PE; Faculty of Medicine and Life Sciences, University of Nottingham, Nottingham, UK., Reynolds LE; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., McKay TR; School of Healthcare Science, Manchester Metropolitan University, Manchester, UK., Wang HW; Institute of Microbiology and Immunology, National Yang Ming University, Taipei City, Taiwan., Ribeiro PS; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Plevin MJ; Department of Biology, University of York, York, UK., Lagos D; Centre for Immunology and Infection, Hull York Medical School and Department of Biology, University of York, York, UK., Lemoine NR; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rajan P; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Graham TA; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Hodivala-Dilke KM; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Spendlove I; Faculty of Medicine and Life Sciences, University of Nottingham, Nottingham, UK., Sharp TV; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK t.sharp@qmul.ac.uk.

المصدر: EMBO molecular medicine [EMBO Mol Med] 2018 Aug; Vol. 10 (8).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: EMBO Press Country of Publication: England NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation, Neoplastic*, Adenocarcinoma/*genetics , Hypoxia-Inducible Factor 1, alpha Subunit/*genetics , Intracellular Signaling Peptides and Proteins/*metabolism , LIM Domain Proteins/*metabolism , Lung Neoplasms/*genetics, Adenocarcinoma/diagnosis ; Adenocarcinoma/metabolism ; Adenocarcinoma/mortality ; Adult ; Aged ; Aged, 80 and over ; Animals ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; Cell Hypoxia/genetics ; Cell Hypoxia/physiology ; Cell Line, Tumor ; Feedback, Physiological ; Female ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Intracellular Signaling Peptides and Proteins/genetics ; LIM Domain Proteins/genetics ; Lung Neoplasms/diagnosis ; Lung Neoplasms/metabolism ; Lung Neoplasms/mortality ; Male ; Mice ; Middle Aged ; Prognosis ; Survival Analysis ; Vascular Endothelial Growth Factor A/genetics

المؤلفون: Bridge KS; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Shah KM; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Li Y; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Foxler DE; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Wong SCK; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Miller DC; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Davidson KM; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Foster JG; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Rose R; School of Biological and Chemical Sciences, Queen Mary University of London, Fogg Building, Mile End Road, London E1 4NS, UK., Hodgkinson MR; Department of Biology, University of York, Heslington, York YO10 5DD, UK., Ribeiro PS; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Aboobaker AA; Department of Zoology, University of Oxford, The Tinbergen Building, South Parks Road, Oxford OX1 3PS, UK., Yashiro K; Cardiac Regeneration and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan., Wang X; Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, IL 60208, USA., Graves PR; Department of Radiation Oncology, New York-Presbyterian Brooklyn Methodist Hospital, 506 6th Street, Brooklyn, NY 11215, USA., Plevin MJ; Department of Biology, University of York, Heslington, York YO10 5DD, UK., Lagos D; Centre for Immunology and Infection, Hull York Medical School and Department of Biology, University of York, Heslington, York YO10 5DD, UK., Sharp TV; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK. Electronic address: t.sharp@qmul.ac.uk.

المصدر: Cell reports [Cell Rep] 2017 Jul 05; Vol. 20 (1), pp. 173-187.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Gene Silencing*, Argonaute Proteins/*metabolism , Intracellular Signaling Peptides and Proteins/*metabolism , LIM Domain Proteins/*metabolism , MicroRNAs/*genetics, Argonaute Proteins/genetics ; Autoantigens/metabolism ; DEAD-box RNA Helicases/metabolism ; HEK293 Cells ; HeLa Cells ; Humans ; Intracellular Signaling Peptides and Proteins/chemistry ; Intracellular Signaling Peptides and Proteins/genetics ; LIM Domain Proteins/chemistry ; LIM Domain Proteins/genetics ; MicroRNAs/metabolism ; Phosphorylation ; Protein Binding ; Protein Processing, Post-Translational ; Proto-Oncogene Proteins/metabolism ; RNA-Binding Proteins/metabolism